Keywords : Vaccine, pediatric vaccine, Rotavirus vaccine, polio vaccine, HiB vaccine, Varicella vaccine, combination vaccine, Haemophilus influenzae type B vaccine, MMR vaccine, Rubella vaccine, Rotateq
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant cont...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.
Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.
Pediatric Vaccines Covered in this Report are as follows:
Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines, Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines
Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other Pediatric Vaccines
All the Pediatric Vaccines in this Report have been Studied from Four View Points:
• Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011
• Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015
• Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015
• Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015
Key Topics Covered in the Report
• Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)
• Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)
• Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)
• By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)
• By Region - Pediatric Disease Cases (2001 – 2011)
• Pediatric Vaccines Doses and Forecast (2005 – 2015)
• Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)
• All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)
• Growth Drivers of Pediatric Vaccines Market
• Challenges of Pediatric Vaccines Market
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
Global Drug And Medication Industry
Table of Contents
1. Executive Summary
2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)
3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)
4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)
5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)
5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market
5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market
5.3 Worldwide – Pediatric Proprietary Vaccines Market
6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast
6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)
6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011)
6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines
6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines
6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)
6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)
6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines
6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
6.3 Polio Vaccines and Forecast (2005 – 2015)
6.3.1 Number of Polio Cases (2001 – 2011)
6.3.2 Number of Polio Vaccines Doses
6.3.3 Immunization Coverage of Polio Vaccines
6.3.4 Market Size of Polio Vaccines
6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)
6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)
6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses
6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines
6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines
6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)
6.5.1 Number of Pneumococcal Cases (2000)
6.5.2 Number of Pneumococcal Vaccines Doses
6.5.3 Immunization Coverage of Pneumococcal Vaccines
6.5.4 Market Size of Pneumococcal Vaccines
6.6 Rotavirus Vaccine and Forecast (2006 – 2015)
6.6.1 Number of Rotavirus Cases (2008 & 2009)
6.6.2 Number of Rotavirus Vaccines Doses
6.6.3 Immunization Coverage of Rotavirus Vaccines
6.6.4 Market Size of Rotavirus Vaccine
6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)
6.7.1 Number of Hepatitis Pediatric Vaccines Doses
6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines
6.7.3 Market Size of Hepatitis Pediatric Vaccines
6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)
6.8.1 Number of Varicella/Chicken Pox Vaccines Doses
6.8.2 Market Size of Varicella/Chicken Pox Vaccines
6.9 Other Pediatric Vaccines and Forecast (2005 – 2015)
6.9.1 Market Size of Other Pediatric Vaccines
7. Growth Drivers of Pediatric Vaccines Market
7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done
7.1.1 Rotavirus Vaccine Introduction
7.1.2 Financial Challenges
7.1.3 Cost Effective
7.1.4 Future Steps
7.1.5 Conclusion
7.2 GAVI Model Increases Vaccine Manufacturers
7.2.1 The Partnership Model
7.2.2 The Business Model
7.3 WHO Global Vaccine Action Plan (2011 - 2020)
8. Challenges of Pediatric Vaccine Market
8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines
8.2 Impediment in Pediatric Vaccine Research & Development
8.3 Barriers to New Entrants in the Pediatric Vaccines Market
List of Figures
Figure 2 1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011
Figure 2 2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015
Figure 3 1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011
Figure 3 2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015
Figure 5 1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011
Figure 5 2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 – 2015
Figure 5 3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011
Figure 5 4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 – 2015
Figure 5 5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011
Figure 5 6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015
Figure 6 1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011
Figure 6 2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015
Figure 6 3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011
Figure 6 4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 – 2015
Figure 6 5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011
Figure 6 6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 – 2015
Figure 6 7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 – 2010
Figure 6 8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011
Figure 6 9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015
Figure 6 10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011
Figure 6 11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015
Figure 6 12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 – 2011
Figure 6 13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 – 2015
Figure 6 14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011
Figure 6 15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015
Figure 6 16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011
Figure 6 17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 – 2015
Figure 6 18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011
Figure 6 19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015
Figure 6 20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011
Figure 6 21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015
Figure 6 22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011
Figure 6 23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 – 2015
Figure 6 24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 – 2011
Figure 6 25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 – 2015
Figure 6 26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025
Figure 6 27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011
Figure 6 28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 – 2015
Figure 6 29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 – 2011
Figure 6 30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 – 2015
Figure 6 31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011
Figure 6 32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015
Figure 6 33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011
Figure 6 34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 – 2015
Figure 6 35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011
Figure 6 36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 – 2015
Figure 6 37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011
Figure 6 38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015
Figure 6 39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011
Figure 6 40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015
Figure 6 41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011
Figure 6 42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015
Figure 6 43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010
Figure 6 44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011
Figure 6 45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015
Figure 6 46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011
Figure 6 47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 – 2015
Figure 6 48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011
Figure 6 49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015
Figure 6 50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011
Figure 6 51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$),2012 – 2015
Figure 7 1: Prices of Childhood Vaccines (US$), 2011
Figure 7 2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012
Figure 7 3: Increasing Number of GAVI Suppliers Based in Emerging Markets
List of Tables
Table 4 1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011
Table 4 2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015
Table 6 1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011
Table 6 2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011
Table 6 3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011
Table 6 4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 – 2011
Table 6 5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011
Table 6 6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011
Table 6 7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011
Table 6 8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011
Table 6 9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011
Table 6 10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000
Table 6 11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number), 2008 – 2009
Table 6 12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009
Table 7 1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020
Table 7 2: Goal-Level Indicators, 2015 & 2020
